Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-14 Purchase |
2024-05-15 4:13 pm |
LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer |
3,188 | $15.68 | $49,988 | 3,188 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-27 7:54 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,405 | $0.7322 | $2,493 | 136,750 (Direct) |
View |
| 2023-11-28 Sale |
2023-11-28 7:06 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,720 | $0.5 | $1,860 | 140,155 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-29 6:47 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,512 | $1.45 | $5,092 | 143,875 (Direct) |
View |
| 2023-05-25 Sale |
2023-05-26 7:29 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,635 | $1.4196 | $5,160 | 147,387 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 6:22 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,599 | $1.6812 | $6,051 | 151,022 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-29 5:33 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,532 | $2.7196 | $9,606 | 154,621 (Direct) |
View |
| 2022-08-26 Sale |
2022-08-29 9:14 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,655 | $4.0162 | $14,679 | 158,153 (Direct) |
View |
| 2022-05-26 Sale |
2022-05-27 5:27 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,596 | $1.9011 | $6,836 | 161,808 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 9:10 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
3,998 | $2.7795 | $11,112 | 165,404 (Direct) |
View |
| 2021-11-26 Sale |
2021-11-29 7:48 pm |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
7,579 | $4.8112 | $36,464 | 169,402 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-09 Option Award |
2025-01-13 5:22 pm |
N/A 2035-01-08 |
LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer |
70,444 | $0 | 70,444 (Direct) |
View |
| 2024-03-21 Option Award |
2024-03-25 8:36 pm |
N/A 2034-03-20 |
LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-03-12 Option Award |
2024-03-13 8:29 pm |
N/A 2034-03-12 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-02-25 Exercise |
2024-02-27 7:54 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 136,750 (Direct) |
View |
| 2023-11-25 Exercise |
2023-11-28 7:06 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 140,155 (Direct) |
View |
| 2023-08-25 Exercise |
2023-08-29 6:47 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,888 | $0 | 143,875 (Direct) |
View |
| 2023-05-25 Exercise |
2023-05-26 7:29 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 147,387 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-17 4:57 pm |
N/A 2033-03-16 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:22 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 151,022 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:33 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 154,621 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:14 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 158,153 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:27 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 161,808 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:35 pm |
N/A 2032-03-17 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
195,000 | $0 | 195,000 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:10 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
6,889 | $0 | 165,404 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:48 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
13,777 | $0 | 169,402 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-29 6:04 pm |
N/A 2029-07-30 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
10,000 | $0 | 155,577 (Direct) |
View |
| 2021-09-28 Exercise |
2021-09-29 6:04 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
10,000 | $0.9 | 155,577 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 5:49 pm |
N/A 2029-07-30 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
12,000 | $0 | 155,577 (Direct) |
View |
| 2021-05-28 Exercise |
2021-06-01 5:49 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
12,000 | $0.9 | 155,577 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:00 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Chevallard Daniel R. CFO and COO |
78,912 | $0 | 78,912 (Direct) |
View |
Ownership |
2021-02-24 8:10 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | Chevallard Daniel R. Chief Executive Officer |
0 | $0 | 320,908 (Direct) |
View |